F552 in Maryland. Pick another state for the same tag.
Against expectation — 2025
Maryland cites F552 less often than its own record predicts
Versus expected share0.55×
0.55 times the national share — cited less often here than elsewhere.
Share of Maryland citations0.30%
Of every deficiency written in Maryland in 2025, this is the portion that was F552.
Maryland0.30%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Maryland surveyors wrote
F552 findings written in Maryland, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJuly 6, 2026
Number of residents sampled:
Number of residents cited:
Based on record review and staff interviews, it was determined that the facility staff failed to ensure consent for psychotropic medications was obtained and maintained in the resident's medical records. This deficient practice was evident for 1 (Resident #2) of 5 residents reviewed for psychotropic medications during the annual survey.The findings include:Psychotropic medication is any drug that affects brain activities associated with mental processes and behavior.On 07/01/2026 at 9:49 AM, a review of Resident #2's medical record revealed the facility identified the resident's family member as a surrogate decision maker in January 2026. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction